Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual...

  • Main
  • 2018 / 05
  • Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual...

Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response

Mease, Philip J., Genovese, Mark C., Weinblatt, Michael E., Peloso, Paul M., Chen, Kun, Othman, Ahmed A., Li, Yihan, Mansikka, Heikki T., Khatri, Amit, Wishart, Neil, Liu, John
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Arthritis & Rheumatology
DOI:
10.1002/art.40579
Date:
May, 2018
File:
PDF, 997 KB
english, 2018
Conversion to is in progress
Conversion to is failed